This holiday-shortened week has brought another string of stellar opportunities for us with both stocks and options, and was an excellent way to close out the first quarter of 2015!
Pazoo, Inc. PZOO
Firstly, our re-alert of PZOO yesterday came just in the nick of time for us to observe a nice upswing. The stock traded up from a low of .0052 to reach .0071, an intraday move of 37% and it did so on more than twice its 30-day average volume.
With the deliberate steps Pazoo has been taking to become actively involved in the cannabis sector, it’s certain to hold our interest for quite awhile. There was a new PR to that effect released after market open yesterday; PZOO’s wholly-owned sub, marijuana testing agency Harris Lee, will be taking full ownership of a “fully functional, revenue generating facility no later than April 30, 2015”. Learn More about Steep Hill @ SteepHillLab.com/colorado
WHIPPANY, N.J., April 1, 2015 (GLOBE NEWSWIRE) — Pazoo, Inc. (OTC Pinks:PZOO) (German WKN#: A1J3DK) is proud to announce that wholly owned subsidiary, Harris Lee, LLC, has entered into a Binding Letter of Intent with Front Range, the Steep Hill licensee for Colorado, to purchase the assets to operate Steep Hill Colorado, a marijuana testing laboratory located in Denver, CO. Additionally, Front Range will transfer all assignable rights and licenses to Harris Lee. >> FULL PR
Visit PZOO @ www.pazoo.com
The new site dedicated to its marijuana testing arm is located @ cannabisking.pazoo.com
Totally Hemp Crazy, Inc. THCZ
Speaking of pot-related plays- Last Friday, we suggested our readers put THCZ on their radars as we were watching the stock search for support. It found it that day at .128, and managed to set higher highs every day since.
Yesterday came an enormous push to an astonishing high of .32; that registered as an overall increase of 150% from THCZ in just five sessions! Even more amazing, is the fact that we observed THCZ trading subpenny as recently as the end of January.
Northstar Global Business Services, Inc. MDIN
MDIN appeared on yesterday’s extended watchlist, and it too enjoyed a nice intraday move of 66%. The stock held the majority of those gains into the close, so we’ll be interested to see how it closes out this short week today.
Pervasip Corp. PVSP
On Monday, we called out PVSP in a well-timed alert that yielded the chance at intraday gains of up to 55% It took until yesterday afternoon for the stock to consolidate and make its way down to find a support level from which to bounce.
That came at .0013, and PVSP did make a nice rebound to the tune of 38% (.0018) This is yet another one which is tied to the cannabis space, so we can definitely see a theme being established here as springtime comes into full-swing.
Petroleo Brasiliero, S.A. (Petrobras) PBR – Options
We signaled May PBR $6 and $6.50 calls last Thursday as we noticed it rebounding off of its newly-established all-time lows. Although there wasn’t much open interest in the May $6 Calls that we highlighted, they were pushed into the money and there was an opportunity to profit for those that decided to take the trade. The low on those contracts was .32 following our alert, and they closed yesterday at .55x.79. With plenty of time left until expiration, we may not yet be finished with them.
There was volume in the May $6.50’s, which traded as low as .22 following our initial mention and yesterday closed at .47; a gain of 114%.
Esperion Therapeutics, Inc. ESPR – Options
It was on Tuesday March 17th that we called ESPR options and came away with percentage gains that ran into the thousands over the course of that week. The idea that we ventured was the 04/17 $90 Calls, and we saw a subsequent run from 3.50 to 28.50.
Following that huge run, we saw those contracts dip back to find support at 4.50 toward the end of last week. Yesterday, a news release helped push ESPR stock to new highs, and as a result the April $90’s went on another big run, up to their closing price of 16.35. That’s a 263% swing in less than a week!
ESPR traded up just shy of $110 in the premarket this morning. We will also want to keep a close eye on the 04/17 $100-110 Calls should the stock continue its upward trend through to next week.
- Here’s Why Esperion Therapeutics Is Rocketing Higher (Wed, Apr 1)
Extended Watchlist:
TXMD, FXCM, RPRX, WBAI, ONVO